Brown Brothers Harriman & Co’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $121K | Buy |
468
+148
| +46% | +$38.2K | ﹤0.01% | 746 |
|
2025
Q1 | $71.6K | Buy |
320
+6
| +2% | +$1.34K | ﹤0.01% | 767 |
|
2024
Q4 | $71.8K | Buy |
314
+37
| +13% | +$8.46K | ﹤0.01% | 803 |
|
2024
Q3 | $67.6K | Buy |
277
+19
| +7% | +$4.64K | ﹤0.01% | 756 |
|
2024
Q2 | $49.4K | Hold |
258
| – | – | ﹤0.01% | 768 |
|
2024
Q1 | $51.1K | Hold |
258
| – | – | ﹤0.01% | 766 |
|
2023
Q4 | $44.4K | Sell |
258
-10
| -4% | -$1.72K | ﹤0.01% | 742 |
|
2023
Q3 | $39.6K | Sell |
268
-535
| -67% | -$79.1K | ﹤0.01% | 741 |
|
2023
Q2 | $175K | Sell |
803
-5
| -0.6% | -$1.09K | ﹤0.01% | 499 |
|
2023
Q1 | $177K | Buy |
808
+501
| +163% | +$110K | ﹤0.01% | 505 |
|
2022
Q4 | $63.9K | Buy |
307
+255
| +490% | +$53.1K | ﹤0.01% | 676 |
|
2022
Q3 | $11K | Sell |
52
-12
| -19% | -$2.54K | ﹤0.01% | 1134 |
|
2022
Q2 | $13K | Buy |
64
+35
| +121% | +$7.11K | ﹤0.01% | 970 |
|
2022
Q1 | $7K | Sell |
29
-11
| -28% | -$2.66K | ﹤0.01% | 1088 |
|
2021
Q4 | $10 | Sell |
40
-114
| -74% | -$29 | ﹤0.01% | 919 |
|
2021
Q3 | $41 | Buy |
154
+125
| +431% | +$33 | ﹤0.01% | 714 |
|
2021
Q2 | $7 | Buy |
29
+6
| +26% | +$1 | ﹤0.01% | 952 |
|
2021
Q1 | $4 | Buy |
23
+19
| +475% | +$3 | ﹤0.01% | 988 |
|
2020
Q4 | $1K | Sell |
4
-20
| -83% | -$5K | ﹤0.01% | 1067 |
|
2020
Q3 | $4K | Hold |
24
| – | – | ﹤0.01% | 852 |
|
2020
Q2 | $5K | Buy |
24
+4
| +20% | +$833 | ﹤0.01% | 823 |
|
2020
Q1 | $3K | Sell |
20
-600
| -97% | -$90K | ﹤0.01% | 885 |
|
2019
Q4 | $96K | Buy |
620
+314
| +103% | +$48.6K | ﹤0.01% | 571 |
|
2019
Q3 | $41K | Buy |
+306
| New | +$41K | ﹤0.01% | 676 |
|
2019
Q1 | – | Sell |
-41
| Closed | -$5K | – | 1090 |
|
2018
Q4 | $5K | Buy |
+41
| New | +$5K | ﹤0.01% | 785 |
|